-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster II

Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 6, 2015: 6:00 PM-8:00 PM
Hall A, Level 2 (Orange County Convention Center)

Jieun Uhm, MD1, Elizabeth Shin2*, Fotios V. Michelis, MD, PhD3, Auro Viswabandya, MD, DM3, Jeffrey H. Lipton, MD, PhD4, Hans A. Messner, M.D./Ph.D3 and Dennis Dong Hwan Kim, MD, PhD5

1Department of Hematology & Oncology, Hanyang University Seoul Hospital, Hanyang University College of Medicine, Seoul, South Korea
2University of Toronto, Toronto, ON, Canada
3Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada
4Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
5Department of Medical Oncology & Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada

Katharina Reinhardt, PhD1*, Rupert Handgretinger, Prof. MD1, Wolfgang Bethge, MD2* and Ursula Holzer, MD1*

1Department of General Paediatrics, Oncology/Haematology, University Children's Hospital, Tuebingen, Germany
2Department of Hematology and Oncology, University of Tuebingen, Tuebingen, Germany

Jin S. Im, MD, PhD1*, Rima M Saliba, Ph.D1*, Susan C Abraham, MD2*, Asif Rashid, MD2*, William Ross, MD3*, Yago Nieto, MD, PhD1, Elizabeth J. Shpall, MD1, Betul Oran, MD1, Amanda Olson1*, Sairah Ahmed, MD1, Uday R. Popat, MD1, Gabriela Rondon, MD1, Muzaffar H. Qazilbash, MD1, Nina Shah, MD1*, Richard E. Champlin, MD1 and Amin M. Alousi, MD1

1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Gastroenterology Hepat & Nutr, The University of Texas MD Anderson Center Center, Houston, TX

Francesco Grimaldi, MD1*, Pilar Perez-Abellan2*, Steven Best, PhD3*, Nicholas Lea, PhD4*, John Veluchamy2*, Muhammad Atif, MD2*, Rosemary Grain2*, Monica Sen2*, Austin G. Kulasekararaj, MBBS, MD, MRCP, FRCPath5*, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA6, Victoria T Potter, MD, FRCPA, FRACP3*, Ghulam J Mufti, FRCP, FRCPath2, Judith C.W. Marsh, MD3 and Linda D Barber, PhD2*

1Department of Haematology University of Naples, Napoli, Italy
2Department of Haematological Medicine, King's College London, London, United Kingdom
3King's College Hospital NHS Foundation Trust, London, United Kingdom
4Laboratory for Molecular Haemato-Oncology, King's College Hospital NHS Foundation Trust/King's College London, London, United Kingdom
5Department of Haematological Medicine, Kings College Hospital NHS Foundation Trust, London, United Kingdom
6Haematology, King's College Hospital NHS Foundation Trust, London, United Kingdom

Yamin Tan1*, Haowen Xiao2*, Jianping Lan3*, Yi Luo4*, Jimin Shi4*, Jingsong He, PhD4*, Xiaoyu Lai5*, Weiyan Zheng4*, Zhen Cai6* and He Huang, MD, PhD7

1The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
2Department of Hematology, Guangzhou General Hospital of Guangzhou Military Command, Guangzhou, China
3Department of Hematology, Zhejiang Provincial People’s Hospital, Hangzhou, China
4Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University, School of Medicine., Hangzhou, China
5Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
6Bone marrow transplantation center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
7Bone Marrow Transplantation Center, the First Affiliated Hospital of Zhejiang University, Hangzhou, China

Mariana Bastos-Oreiro, MD1,2*, Pascual Balsalobre, PhD2,3*, Diana Champ, MD1*, Juan Churruca, MD1*, Maria Jesus Pascual, MD4*, Pilar Herrera, MD5*, Leyre Bento, MD6*, Jose Luis Piñana, MD7*, Santiago Jimenez, MD8*, Karem Humala, MD9*, Pau Montesinos, MD10*, Inmaculada Heras, MD11*, Almudena Iglesias, MD12*, Ana Perez-Corral, MD1*, Cristina Pascual, MD1*, Carolina Martinez-Laperche, PhD1*, Mi Kwon, MD1,2*, Jorge Gayoso, MD1,2* and Jose L. Diez-Martin, MD, PhD13,14

1Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain
2Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
3Hospital General Universitario Gregorio Marañón, Madrid, Spain
4Hematology, Hospital Carlos Haya, Málaga, Spain
5Hematology, Hospital Ramón y Cajal, Madrid, Spain
6Hospital Son Espases, Palma de Mallorca, Spain
7Hematology, Hospital Clínico de Valencia, Valencia, Spain
8Hematology, Hospital Clínico Universitario Dr Negrin, Las palmas de gran canaria, Spain
9Hematology, Hospital Universitario La Paz, Madrid, Spain
10Hematology, Hospital Universitari i Politècnic La Fe de Valencia, Valencia, Spain
11Hematology and Medical Oncology Department, Hospital Morales Meseguer. Centro Regional de Hemodonación. Universidad de Murcia. IMIB, MURCIA, Spain
12Hematology, Hospital Puerta de Hierro, Madrid, Spain
13Gregorio Marañón Health Research Institute (IISGM), Madrid, Spain
14Department of Hematology, Gregorio Marañon General University Hospital, Madrid, Spain

Hanna Jean Khoury, MD1, Tao Wang, PhD2,3*, Mukta Arora, MD4, Michael Hemmer, MS5*, Stephen R. Spellman, MBS6*, Corey S Cutler, MD, MPH7, Daniel R. Couriel, MD8, Amin M. Alousi, MD9 and Joseph A. Joseph, MD10

1Emory University, Atlanta, GA
2CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
3CIBMTR (Center for International Blood and Marrow Transplant Research), Medical Colfdgfdgdfg, Milwaukee, WI, US Virgin Islands
4Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
5CIBMTR (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI
6CIBMTR® (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match®, Minneapolis, MN
7Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
8University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
9Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
10H. Lee Moffitt Cancer Center, Tampa, FL

Jennifer Whangbo, MD, PhD1,2, John Koreth, MBBS, DPhil3, Haesook T. Kim, PhD4*, Katharine Dusenbury1*, Ana Cristina Alho, MD1*, Carol G Reynolds, PhD1*, Marie J Chammas1*, Kyle T Jones5*, Sarah Nikiforow, MD, PhD6, Corey S Cutler, MD, MPH6, Vincent T. Ho, MD3, Philippe Armand, MD, PhD6, Edwin P. Alyea, MD6, Robert J. Soiffer, MD3, Joseph H. Antin, MD6 and Jerome Ritz, MD1

1Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA
2Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA
3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
4Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston, MA
5Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
6Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Floris C. Loeff*, J.H. Frederik Falkenburg, MD, PhD, Lois Hageman*, Sabrina A.J. Veld*, Marian van de Meent*, Constantijn J.M. Halkes, MD, PhD and Inge Jedema, PhD

Department of Hematology, Leiden University Medical Center, Leiden, Netherlands

Rohtesh S. Mehta, MD, MPH, MS1, Rima M Saliba, Ph.D2*, Julianne Chen2*, Gabriela Rondon, MD2, Aimee E Hammerstrom, PharmD, BCOP2*, Amin M. Alousi, MD2, Muzaffar H. Qazilbash, MD2, Qaiser Bashir, MD2, Sairah Ahmed, MD2, Uday R. Popat, MD2, Chitra M. Hosing, MD2, Issa F. Khouri2, Elizabeth J. Shpall, MD2, Richard E. Champlin, MD2 and Stefan O. Ciurea, MD2

1Hematology Oncology Transplantation, University of Minnesota, Minneapolis, MN
2Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

Brittany Knick Ragon, MD1, Alison M Gulbis2*, Rima M Saliba, Ph.D3*, Julianne Chen3*, Gabriela Rondon, MD3, Uday R. Popat, MD3, Yago Nieto, MD, PhD3, Betul Oran, MD3, Amanda L. Olson, MD3*, Krina Patel, MD3, Chitra M. Hosing, MD3, Muzaffar H. Qazilbash, MD3, Nina Shah, MD3*, Partow Kebriaei, MD3, Elizabeth J. Shpall, MD3, Richard E. Champlin, MD3 and Amin M. Alousi, MD3

1Hematology/Oncology Fellowship, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
2Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

Yngvar Floisand, M.D PhD1*, Knut Lundin, M.D PhD1*, Vladimir Lazarevic, MD2*, Jorn Dehli Kristiansen, RN1*, Liv T. N. Osnes, MD, PhD3*, Geir E. Tjonnfjord, MD, PhD4, Henrik Mikael Reims, M.D PhD1* and Tobias Gedde-Dahl, M.D PhD1*

1Oslo University Hospital - Rikshospitalet, Oslo, Norway
2Hematology, Lund University Hospital, Lund, Sweden
3Oslo University Hospital - Rikshospital, Oslo, Norway
4Department of Hematology, Oslo University Hospital, Rikshospitalet, Oslo, Norway

Lena Von Bahr, MD1,2*, Lindsay Davies, PhD1*, Gabriel Afram, MD2*, Carina Modin2*, Karin Garming-Legert, PhD3*, Hans Hägglund, MD, PhD4*, Per T. Ljungman, MD, PhD2 and Katarina Le Blanc, M.D., Ph.D.1,2

1Dep of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden
2Hematology Center, Karolinska University Hospital, Stockholm, Sweden
3Department of Dental Medicine, Karolinska Institutet, Stockholm, Sweden
4Department of Medicine Huddinge, Karolinska Institutet, and Hematology Center, Karolinska University Hospital, Stockholm, Sweden, Stockholm, Sweden

Jieun Uhm, MD1, Elizabeth Shin2*, Marc Poch Martell, MD3*, Fotios V. Michelis, MD, PhD3, Auro Viswabandya, MD, DM3, Jeffrey H. Lipton, MD, PhD4, Hans A. Messner, M.D./Ph.D3 and Dennis Dong Hwan Kim, MD, PhD5

1Department of Hematology & Oncology, Hanyang University Seoul Hospital, Hanyang University College of Medicine, Seoul, South Korea
2University of Toronto, Toronto, ON, Canada
3Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada
4Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
5Department of Medical Oncology & Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada

Yu-tong Wang1*, Yuan Kong, MD, PhD1*, Yang Song2*, Zheng-Fan Jiang2* and Xiao-jun Huang1,2

1Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of HSCT, Beijing, China
2Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China

Claire Breal1*, Catherine Mohr1*, Fanny Sauvestre2*, Marion Marty2*, Jean-francois Goussot2*, Genevieve Belleannee2*, Reza Tabrizi1, Stephane Vigouroux1* and Noel Milpied1

1Hematology, University Hospital of Bordeaux, Pessac, France
2Pathology, University Hospital of Bordeaux, Pessac, France

Mohamed A. Kharfan-Dabaja, M.D.1,2, Rocio Parody, M.D.3*, Janelle Perkins, PharmD4,5*, Oriana Lopez-Godino, M.D.6*, Lucia Lopez-Corral, M.D.6*, Lourdes Vazquez, M.D.6*, Dolores Caballero, MD6*, Jose Falantes, M.D.7*, Jamie Shapiro, PharmD8*, Guillermo Orti, M.D.9*, Pere Barba, M.D.9*, David Valcárcel, MD, PhD10, Alber Esquirol, M.D.11*, Rodrigo Martino, MD, PhD11, Jose Luis Piñana, M.D.12*, Carlos Solano, M.D.13, Joseph A Pidala, M.D., PhD1, Claudio Anasetti, M.D.5 and Jose A. Perez-Simon, M.D., PhD3

1Blood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL
2Dept. of Oncologic Sciences, University of South Florida, Morsani College of Medicine, Tampa, FL
3Dept. of Hematology, Hospital Universitario Virgen del Rocío, Sevilla, Spain
4University of South Florida College of Pharmacy, Tampa, FL
5Dept. of Blood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL
6Hospital Universitario de Salamanca, Salamanca, Spain
7Department of Hematology, Hospital Universitario Virgen del Rocío, Sevilla, Spain
8Dept. of Pharmacy, Moffitt Cancer Center, Tampa, FL
9Hospital Universitario Valld'Hebron, Barcelona, Spain
10Hospital Vall d'Hebrón, Barcelona, Spain
11Hospital Santa Creu i Sant Pau, Barcelona, Spain
12Hematology Department, Hospital Clinico de Valenci, Valencia, Spain
13Hospital Clinico de Valenci, Valencia, Spain

Yue Han, MD*, Jie Wang*, Jia Chen*, Jiaqian Qi*, Jian Su*, Zhenni Ma*, Yaqiong Tang*, Wei Han*, Aining Sun, PhD*, Zhaoyue Wang*, Changgeng Ruan, M.D., Ph.D. and Wu Depei, MD

Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, China

Se young Han, MD1*, Pavan Kumar Bhamidipati, MBBS, MD2, Khoan Vu, M.D.1, John F Dipersio, MD, PhD2, Feng Gao, PhD3*, Iskra Pusic, MD4, Geoffrey L. Uy, MD5, Peter Westervelt, MD, PhD6, Ravi Vij, MD2, Mark A. Schroeder, MD4, Camille N. Abboud, MD, FACP4, Keith Stockerl-Goldstein, MD7, Amanda F. Cashen, MD2, Todd A Fehniger, MD, PhD4 and Rizwan Romee, MD4

1Department of Medicine, Washington University School of Medicine, Saint Louis, MO
2Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO
3Department of Biostatistics, Washington University School of Medicine, Saint Louis, MO
4BMT and Leukemia Program, Washington University School of Medicine, Saint Louis, MO
5Division of Oncology, Washington University School of Medicine, Saint Louis, MO
6Division of Oncology, Washington University School of Medicine, St. Louis, MO
7Department of Medicine, Division of Oncology, Washington University School of Medicine, St Louis, MO

Ye Zhao1*, Yuanyuan Chen2*, Haiyan Liu2* and Wu Depei, MD1

1Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, China
2Soochow University, Suzhou, China

Marijn Aletta Gillissen, MD1,2*, Martijn Kedde2*, Etsuko Yasuda, PhD2*, Sophie E. Levie2*, Arjen Q. Bakker2*, Yvonne B. Claassen2*, Martino Bohne2*, Dave Speijer, PhD3*, Daisy I. Picavet4*, Jan Stap4*, Marinus H. J. van Oers1, Tim Beaumont, PhD2*, Pauline M. van Helden, PhD2*, Hergen Spits, PhD2* and Mette D. Hazenberg, MD, PhD1*

1Department of Hematology, Academic Medical Center Amsterdam, Amsterdam, Netherlands
2AIMM Therapeutics, Amsterdam, Netherlands
3Medical Biochemistry, Academic Medical Center Amsterdam, Amsterdam, Netherlands
4Core facility Cellular Imaging, Academic Medical Center Amsterdam, Amsterdam, Netherlands

Kazutaka Ozeki, MD, PhD1, Yukiyasu Ozawa, MD2*, Naomi Kawashima, MD3*, Yusuke Yamaga, MD1*, Yoshitaka Adachi, MD1*, Koji Umemura, MD1*, Shoichiro Okazaki, MD1*, Akio Kohno, MD, PhD1*, Koichi Miyamura, MD, PhD3 and Yoshihisa Morishita, MD, PhD1,4

1Hematology and Oncology, JA Aichi Konan Kosei Hospital, Konan, Japan
2Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
3Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
4Holy Spirit Hospital, Nagoya, Japan

Armin Rashidi, MD, PhD1, Tandon Bevan, MD2* and Amanda F. Cashen, MD3

1Division of Oncology, Washington University School of Medicine, Saint Louis, MO
2Division of Molecular Pathology,, Washington University School of Medicine, St. Louis, MO
3Division of Oncology, Washington University School of Medicine, St. Louis, MO

Stephanie Thiant, PhD1*, Jean Roy, MD2, Jessica Trottier3*, Marie-Pier Giard3*, Rachel Parat3*, Denis-Claude Roy, MD4 and Martin Guimond, PhD5*

1Division of Hematology-Oncology, Hôpital Maisonneuve Rosemont, MONTREAL, QC, Canada
2Division of Hematology and Oncology, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada
3Research Center, Hopital Maisonneuve Rosemont, MONTREAL, QC, Canada
4Department of Hematology and Cellular Therapy Laboratory, Hôpital Maisonneuve-Rosemont, University of Montreal, Montreal, QC, Canada
5University of Montreal, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada

Crisitina Skert1*, Simone Perucca1*, Imberti Luisa2*, Chiarini Marco3*, Michele Malagola1, Carla Filì1*, Viviana Giustini, MSC4*, Claudia Ghidini, BSC4*, Federica Cattina1*, Alessandro Turra1*, Valeria Cancelli1*, Simona Bernardi5* and Domenico Russo1

1Unit of Blood Diseases and Stem Cells Transplantation, University of Brescia, A.O. Spedali Civili of Brescia, Brescia, Italy
2Centro Ricerca Emato-oncologica AIL (CREA), Diagnostic department, Spedali Civili of Brescia, Brescia, Italy
3Centro Ricerca Emato-oncologica AIL (CREA), Diagnostic Department, Spedali Civili of Brescia, Brescia, Italy
4Centro di Ricerca Emato-oncologica AIL, AO Spedali Civili, Brescia, Italy
5Unit of Blood Diseases and Stem Cells Transplantation, University of Brescia, Brescia, Italy

Schoemans Helene1*, Kathy Goris1*, Raf Van Durm1*, Jasper Van Hoof1*, Hildegard T. Greinix, MD2, Daniel Wolff3*, Steven Z. Pavletic, MD4, Stephanie J. Lee, MD, MPH5, Johan Maertens, MD, PhD6*, Sabina De Geest, PhD RN7*, Fabienne Dobbels1* and Rafael F. Duarte, MD, PhD8

1University Hospitals of Leuven, Leuven, Belgium
2Hematology, Medical University Graz, Graz, Austria
3University of Regensburg, Regensburg, Germany
4Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD
5Fred Hutchinson Cancer Research Center, Seattle, WA
6Department of Hematology, University Hospital Gasthuisberg Leuven, Leuven, Belgium
7Health Services Research, KU Leuven, Leuven, Belgium
8Department of Hematology. Hospital Universitario Puerta de Hierro, Madrid, Spain

Carolina Costa-Lima, MD*, Eliana Cristina Martins Miranda, PhD*, Marcos Paulo Colella, MD*, Francisco José Penteado Aranha, MD, PhD*, Carmino Antônio De Souza, MD, PhD, Afonso Celso Vigorito, MD, PhD* and Erich Vinicius De Paula, MD, PhD

Hematology and Hemotherapy Center, University of Campinas, Campinas, SP, Brazil

Julia Muñoz-Ballester1*, Tzu Hua Chen-Liang1*, Ana María Hurtado1*, Pastora Iniesta1*, María Dolores García-Malo1*, José Bartolomé Nieto1*, José Padilla1*, Raul Teruel Montoya, PhD1, Maria del Mar Osma1*, María Luisa Lozano2*, Felipe de Arriba, MD PhD1*, Francisco José Ortuño1*, Inmaculada Heras, MD1*, Vicente Vicente1*, Cristina Castilla-Llorente1* and Andres Jerez1*

1Hematology and Medical Oncology Department, Hospital Morales Meseguer. Centro Regional de Hemodonación. Universidad de Murcia. IMIB, MURCIA, Spain
2Hematology and Medical Oncology Department. University . IMIB, Hospital Morales Meseguer. Centro Regional de Hemodonación. Universidad de Murcia. IMIB, MURCIA, Spain

Andrew C. Harris, MD1,2, Rachel Young2*, Steven M. Devine, MD3, William J Hogan, MBChB4, Francis Ayuk, M.D.5*, Udomsak Bunworasate6, Chantiya Chanswangphuwana, MD6*, Yvonne A Efebera, MD3, Ernst Holler, MD, PhD7*, Mark R Litzow, MD4, Rainer Ordemann, MD8*, Muna Qayed, MD, MSc9, Anne S. Renteria, MD10, Ran Reshef, MD11, Matthias Wölfl, MD12*, Yi-Bin Chen, MD13, Steven Goldstein, MD2*, Madan H. Jagasia14, Franco Locatelli, MD, PhD15, Stephan Mielke, MD12, David L Porter, MD16, Tal Schechter, MD17*, Zhanna Shekhovtsova, MD18*, James L.M. Ferrara, MD, DSc10 and John E. Levine, MD, MS2,19,20

1University of Utah, Primary Children's Medical Center, Salt Lake City, UT
2University of Michigan, Ann Arbor, MI
3The Ohio State University, Columbus, OH
4Division of Hematology, Mayo Clinic, Rochester, MN
5University Medical Center Hamburg-Eppendorf, Hamburg, Germany
6Chulalongkorn University, Bangkok, Thailand
7University of Regensburg, Regensburg, Germany
8University Hospital TU Dresden, Dresden, Germany
9Emory University, Atlanta, GA
10Mount Sinai Medical Center, New York, NY
11Columbia University Medical Center, New York, NY
12University of Würzburg, Würzburg, Germany
13Massachusetts General Hospital, Boston, MA
14Department of Medicine, Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN
15University of Pavia, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy
16Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
17The Hospital for Sick Children, Toronto, Canada
18Federal Center for Pediatric Hematology, Moscow, Russia
19Blood and Marrow Transplant Program, Mount Sinai School of Medicine, New York, NY
205303 Cancer Center, Univ. of Michigan Medical Ctr., Ann Arbor, MI

*signifies non-member of ASH